We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+11.82%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$223M
AUM Growth
-$42M
(-16%)
Cap. Flow
-$61.6M
Cap. Flow
% of AUM
-27.61%
Top 10 Holdings %
Top 10 Hldgs %
67.81%
Holding
57
New
8
Increased
3
Reduced
13
Closed
16
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
+$23.6M |
| 2 |
Maximus
MMS
|
+$13.9M |
| 3 |
Annexon
ANNX
|
+$8.5M |
| 4 |
Relay Therapeutics
RLAY
|
+$7.07M |
| 5 |
IDEAYA Biosciences
IDYA
|
+$4.66M |
Top Sells
| 1 |
Teleflex
TFX
|
+$16.8M |
| 2 |
Labcorp
LH
|
+$16M |
| 3 |
Smith & Nephew
SNN
|
+$14.4M |
| 4 |
Organon & Co
OGN
|
+$12.6M |
| 5 |
GSK
GSK
|
+$12M |
Sector Composition
| 1 | Healthcare | 88.55% |
| 2 | Industrials | 6.48% |
| 3 | Consumer Staples | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Labcorp
LH
$22.6B
| $38.7M | 17.35% |
173,293
-72,609
| -30% | -$16M |
|
|
2
Teva Pharmaceuticals
TEVA
$37.1B
| $24.3M | 10.89% |
+1,349,274
| New | +$23.6M |
|
|
3
Maximus
MMS
$3.03B
| $14.5M | 6.48% |
+155,142
| New | +$13.9M |
|
4
Zimmer Biomet
ZBH
$17.6B
| $13.8M | 6.17% |
127,511
-27,793
| -18% | -$3.03M |
|
|
VXRT
5
DELISTED
Vaxart
VXRT
| $11.6M | 5.18% |
13,608,244
-1,156,747
| -8% | -$884K |
|
6
Kenvue
KVUE
$36B
| $11M | 4.92% |
474,741
-10,259
| -2% | -$213K |
|
|
7
Teleflex
TFX
$5.76B
| $9.71M | 4.35% |
39,272
-71,806
| -65% | -$16.8M |
|
8
Tyra Biosciences
TYRA
$1.96B
| $9.42M | 4.22% |
400,870
-199,424
| -33% | -$4.19M |
|
9
Disc Medicine
IRON
$2.87B
| $9.24M | 4.14% |
187,941
-4,059
| -2% | -$191K |
|
10
Cigna
CI
$80.2B
| $9.18M | 4.11% |
26,503
-283
| -1% | -$97.4K |
|
|
11
Annexon
ANNX
$909M
| $8.48M | 3.8% |
+1,433,155
| New | +$8.5M |
|
12
Biodesix
BDSX
$219M
| $7.72M | 3.46% |
216,926
-467
| -0.2% | -$16.1K |
|
|
13
Relay Therapeutics
RLAY
$4.16B
| $6.7M | 3% |
+945,839
| New | +$7.07M |
|
14
Erasca
ERAS
$6.06B
| $6.06M | 2.71% |
2,219,186
-655,350
| -23% | -$1.85M |
|
|
CMPS
15
Compass Pathways
CMPS
$1.81B
| $5.76M | 2.58% |
914,639
+621,222
| +212% | +$4.38M |
|
|
ATXS
16
DELISTED
Astria Therapeutics
ATXS
| $5.56M | 2.49% |
504,887
-5,380
| -1% | -$59.8K |
|
17
PMV Pharmaceuticals
PMVP
$75.7M
| $4.79M | 2.15% |
3,214,239
+505,831
| +19% | +$782K |
|
|
VTYX
18
DELISTED
Ventyx Biosciences
VTYX
| $4.3M | 1.93% |
1,971,948
+1,193,024
| +153% | +$2.74M |
|
|
19
IDEAYA Biosciences
IDYA
$3.53B
| $3.9M | 1.75% |
+123,000
| New | +$4.66M |
|
20
Artivion
AORT
$1.12B
| $3.23M | 1.45% |
+121,178
| New | +$3.15M |
|
|
CRGX
21
DELISTED
CARGO Therapeutics
CRGX
| $3.21M | 1.44% |
+173,860
| New | +$3.11M |
|
22
Context Therapeutics
CNTX
$57.2M
| $2.6M | 1.17% |
1,328,352
| – | – |
|
23
Enanta Pharmaceuticals
ENTA
$381M
| $1.83M | 0.82% |
177,004
| – | – |
|
24
Nuvation Bio
NUVB
$2.05B
| $1.53M | 0.69% |
668,115
| – | – |
|
25
Foghorn Therapeutics
FHTX
$316M
| $1.13M | 0.51% |
121,672
| – | – |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA